A SINGLE-ARM, OPEN-LABEL, PHASE I STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF OBE-CEL IN PARTICIPANTS WITH REFRACTORY PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS
AUTO1-MS1
Phase 1 other active
Quick answer
A SINGLE-ARM, OPEN-LABEL, PHASE I STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF OBE-CEL IN PARTICIPANTS WITH REFRACTORY PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS for Refractory Progressive Multiple Sclerosis is a Phase 1 program (other) at Autolus GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Autolus GmbH
- Indication
- Refractory Progressive Multiple Sclerosis
- Phase
- Phase 1
- Modality
- other
- Status
- active